BlackRock, Inc. 13D and 13G filings for Avanos Medical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-30 12:02 pm Sale | 2025-03-31 | 13G | Avanos Medical, Inc. AVNS | BlackRock Inc. BLK | 6,826,353 14.800% | -634,990 (-8.51%) | Filing |
| 2024-01-22 2:03 pm Sale | 2023-12-31 | 13G | Avanos Medical, Inc. AVNS | BlackRock Inc. BLK | 7,461,343 16.100% | -109,705 (-1.45%) | Filing |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | Avanos Medical, Inc. AVNS | BlackRock Inc. BLK | 7,571,048 16.300% | 0 (Unchanged) | Filing |
| 2023-01-20 09:43 am Sale | 2022-12-31 | 13G | Avanos Medical, Inc. AVNS | BlackRock Inc. BLK | 7,571,048 16.300% | -42,400 (-0.56%) | Filing |
| 2022-01-27 5:13 pm Unchanged | 2021-12-31 | 13G | Avanos Medical, Inc. AVNS | BlackRock Inc. BLK | 7,613,448 15.800% | 0 (Unchanged) | Filing |
| 2022-01-26 09:16 am Purchase | 2021-12-31 | 13G | Avanos Medical, Inc. AVNS | BlackRock Inc. BLK | 7,613,448 15.800% | 2,290,107 (+43.02%) | Filing |
| 2021-01-26 6:52 pm Sale | 2020-12-31 | 13G | Avanos Medical, Inc. AVNS | BlackRock Inc. BLK | 5,323,341 11.100% | -228,417 (-4.11%) | Filing |